Protagonist Therapeutics Inc (PTGX)

Current ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total current assets	US$ in thousands	591,641	476,769	570,925	627,553	355,577	324,881	316,941	235,736	237,355	276,617	304,302	341,522	340,736	327,687	371,818	285,508	315,606	204,151	217,466	125,986
Total current liabilities	US$ in thousands	47,398	44,578	41,578	39,910	21,274	27,867	26,398	23,229	31,179	36,754	40,088	43,456	44,016	39,156	42,973	34,515	40,241	38,563	35,360	36,372
Current ratio		12.48	10.70	13.73	15.72	16.71	11.66	12.01	10.15	7.61	7.53	7.59	7.86	7.74	8.37	8.65	8.27	7.84	5.29	6.15	3.46

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $591,641K ÷ $47,398K
= 12.48

Protagonist Therapeutics Inc has demonstrated a consistently strong current ratio over the past few years, indicating a healthy liquidity position. The current ratio has shown an increasing trend, starting at 3.46 in March 2020 and peaking at 16.71 in December 2023. This implies that the company has more than enough current assets to cover its current liabilities during these periods.

While there has been some fluctuation in the current ratio in more recent periods, dropping to 10.70 in September 2024, the ratio remains above 1, suggesting that Protagonist Therapeutics Inc continues to have sufficient short-term assets to meet its short-term obligations. Overall, the company's current ratio reflects a strong liquidity position, providing a buffer against potential financial risks and uncertainties.